CARSGEN-B: INTERIM REPORT 2024
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
CARSGEN-B: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2024
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OFCONFIRMATORY PHASE II CLINICAL TRIAL OFSATRICABTAGENE AUTOLEUCEL IN CHINA
CARSGEN-B: DATE OF BOARD MEETING
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: VOLUNTARY ANNOUNCEMENT -SHAREHOLDING INCREASE BY THE SUBSTANTIAL SHAREHOLDERAND SHARE REPURCHASE BY THE COMPANY
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: VOLUNTARY ANNOUNCEMENT - UPDATED PHASE II RESULTS ON ZEVOR-CEL AND FIRST-IN-HUMAN CT071 RESULTS PRESENTED AT THE EHA 2024 ANNUAL CONGRESS
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Next Day Disclosure Return
CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
No Data
No Data